Structure Therapeutics recently reported positive topline Phase 2b and related ACCESS program data for its oral GLP-1 agonist aleniglipron in adults with obesity or overweight, showing clinically ...

Using Georgia State’s CHARA Array, an international team of scientists has uncovered unexpected complexity in how stars ...

Whether you’re an aspiring songwriter, just starting out, or an old pro, it’s helpful to look at the parts of a song and how best to arrange them. Playing with structure requires both sides of the ...

A thick layer of more than 12 miles of rock may explain why Bermuda seems to float above the surrounding ocean. When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

A team of Italian scientists took the world by storm last March when they announced the discovery of a colossal underground complex plunging nearly 3,500 feet beneath Egypt's Giza Plateau and linking ...

Enrich 2025 is centred around reimagining the energy enterprise. What, in your view, is the single biggest disruptor shaping this reimagination? It is AI. Over the last two to three years, AI has ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...

In a post-Metsera world, Structure TherapeuticsGPCR could be the next big takeover candidate, analysts said Tuesday, as Big Pharma scrambles to play catch-up in the blazing hot obesity space. The ...

A limited liability company (LLC) is a business structure combining the tax advantages of a partnership with the liability protections of a corporation. Many, or all, of the products featured on this ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...